The markedly improved survival of the mouse model of Menkes disease treated with ES-Cu (349) demonstrated a major role of mitochondria in Menkes disease pathogenesis as well as a relatively higher importance of ATP7A activity in brain barriers compared to brain cells. Here, ATP7A is linked to Menkes disease.